Published May 18, 2022
| Version v1
Report
Open
Contextual factors influencing intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) uptake
Creators
- 1. Emory University, Atlanta, United States of America
- 2. Liverpool School of Tropical Medicine, Liverpool, United Kingdom
- 3. Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America
Description
Report considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.1 Intermittent preventive treatment of malaria in pregnancy (IPTp)” of the WHO Guidelines for malaria, 3 June 2022.
Files
Rodriguez-et-al-2022-contextual-factors-influencing-IPTp-SP-uptake.pdf
Files
(1.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:32b35d5ef21ad2726ef9d3be122b36bf
|
1.3 MB | Preview Download |